Ellison accused Novo Nordisk, Eli Lilly and Sanofi of inflating patients' out-of-pocket costs for insulin based on the wholesale acquisition cost, or list price, of the drug. The drugmakers were ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus ... charging PBMs with driving up prices for specialty drugs to treat ...

He added his office’s goal is to make sure insulin prices do not increase after these five years. During the press conference, Ellison said diabetic patients were paying about $6,000 a year on ...

Ok, wait, according to USA Today, the entire reason Costco changed to Pepsi more than a decade ago was so the beloved $1.50 combo didn't increase. As of now, the beloved combo price is staying as is.

As of Jan. 23, 2025, Trump has not gotten rid of Medicare’s $35 cap on insulin prices, nor has he changed the $35 cap on out-of-pocket costs for some insulin products sold to Americans not on ...

Indianapolis-based drugmaker Eli Lilly and Company has announced price ... (insulin glargine-aglr) injection, a basal insulin that is biosimilar to and interchangeable with Lantus (insulin ...